Doyle Anthony 4
4 · BIOCRYST PHARMACEUTICALS INC · Filed Nov 24, 2021
Insider Transaction Report
Form 4
Doyle Anthony
Chief Financial Officer
Transactions
- Purchase
Common Stock
2021-11-23$12.48/sh+35,258$440,020→ 93,719 total
4 · BIOCRYST PHARMACEUTICALS INC · Filed Nov 24, 2021
Common Stock